| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |